Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials
暂无分享,去创建一个
A. Tobin | D. Nwakanma | A. Amambua-Ngwa | Amit Mahindra | A. Jamieson | M. Alam | O. Janha | Kopano Mapesa | A. Sanchez-Azqueta | Mahmood M. Alam | A. Sánchez-Azqueta